Beer M - Search Results

1

Zoonoses Anticipation and Preparedness Initiative, stakeholders conference, February 4 & 5, 2021.

Beer M, Amery L, Bosch BJ, Brix A, Daramola O, Inman S, Jungbäck C, Kortekaas J, Lindo V, Okorji-Obike U, Rodriguez-Conde S, Tang A, Tchelet R, Vandeputte J, Wichgers Schreur PJ, Osterhaus A, Haagmans B, Audonnet JC. Beer M, et al. Biologicals. 2021 Nov;74:10-15. doi: 10.1016/j.biologicals.2021.10.003. Epub 2021 Nov 1. Biologicals. 2021. PMID: 34736782 Free PMC article.

2

Multimeric single-domain antibody complexes protect against bunyavirus infections.

Wichgers Schreur PJ, van de Water S, Harmsen M, Bermúdez-Méndez E, Drabek D, Grosveld F, Wernike K, Beer M, Aebischer A, Daramola O, Rodriguez Conde S, Brennan K, Kozub D, Søndergaard Kristiansen M, Mistry KK, Deng Z, Hellert J, Guardado-Calvo P, Rey FA, van Keulen L, Kortekaas J. Wichgers Schreur PJ, et al. Among authors: beer m. Elife. 2020 Apr 21;9:e52716. doi: 10.7554/eLife.52716. Elife. 2020. PMID: 32314955 Free PMC article.

3

Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.

Okba NMA, Widjaja I, van Dieren B, Aebischer A, van Amerongen G, de Waal L, Stittelaar KJ, Schipper D, Martina B, van den Brand JMA, Beer M, Bosch BJ, Haagmans BL. Okba NMA, et al. Among authors: beer m. Emerg Microbes Infect. 2020 Dec;9(1):1080-1091. doi: 10.1080/22221751.2020.1760735. Emerg Microbes Infect. 2020. PMID: 32471334 Free PMC article.

4

Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model.

Aebischer A, Wernike K, König P, Franzke K, Wichgers Schreur PJ, Kortekaas J, Vitikainen M, Wiebe M, Saloheimo M, Tchelet R, Audonnet JC, Beer M. Aebischer A, et al. Among authors: beer m. Vaccines (Basel). 2021 Jun 15;9(6):651. doi: 10.3390/vaccines9060651. Vaccines (Basel). 2021. PMID: 34203630 Free PMC article.

5

Vaccine development against Schmallenberg virus: from classical inactivated to modified-live to scaffold particle vaccines.

Wernike K, Aebischer A, Audonnet JC, Beer M. Wernike K, et al. Among authors: beer m. One Health Outlook. 2022 Aug 17;4(1):13. doi: 10.1186/s42522-022-00069-8. One Health Outlook. 2022. PMID: 35978443 Free PMC article. Review.

6

Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.

Leifer I, Lange E, Reimann I, Blome S, Juanola S, Duran JP, Beer M. Leifer I, et al. Among authors: beer m. Vaccine. 2009 Nov 5;27(47):6522-9. doi: 10.1016/j.vaccine.2009.08.057. Epub 2009 Sep 2. Vaccine. 2009. PMID: 19732859

7

Classical swine fever.

Moennig V, Becher P, Beer M. Moennig V, et al. Among authors: beer m. Dev Biol (Basel). 2013;135:167-74. doi: 10.1159/000178522. Epub 2013 May 14. Dev Biol (Basel). 2013. PMID: 23689894

8

Schmallenberg virus.

Wernike K, Hoffmann B, Beer M. Wernike K, et al. Among authors: beer m. Dev Biol (Basel). 2013;135:175-82. doi: 10.1159/000312546. Epub 2013 May 14. Dev Biol (Basel). 2013. PMID: 23689895

9

Inactivated Schmallenberg virus prototype vaccines.

Wernike K, Nikolin VM, Hechinger S, Hoffmann B, Beer M. Wernike K, et al. Among authors: beer m. Vaccine. 2013 Aug 2;31(35):3558-63. doi: 10.1016/j.vaccine.2013.05.062. Epub 2013 May 23. Vaccine. 2013. PMID: 23707449

10

The N-terminal domain of Schmallenberg virus envelope protein Gc is highly immunogenic and can provide protection from infection.

Wernike K, Aebischer A, Roman-Sosa G, Beer M. Wernike K, et al. Among authors: beer m. Sci Rep. 2017 Feb 13;7:42500. doi: 10.1038/srep42500. Sci Rep. 2017. PMID: 28211908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,663 results

Search Page